The value of single cell sequencing is now cemented in the annals of the life science industry – and as a result, new methods and technologies are emerging that allow scientists to sequence more and more cells at a lower and lower cost. The ability to multiplex millions of cells at a reduced cost ...
In today's dynamic biotech and biomedicine sectors, the transformative power of artificial intelligence (AI) stands at the forefront in R&D. To leverage AI to its full potential, it’s key to understand the nuanced, strategic advancements it brings - especially when grappling with complex ...
In order to study a biological system as a whole, it’s beneficial to merge the input of different biological features. That means taking into account not only the proteome, transcriptome, and genome, but also the abundance of post-translational modifications and microbiome factors that can ...
Biology has been associated with microscopy as its primary tool for several hundred years. Since the second half of the twentieth century biochemical and subsequently molecular biology methods truly revolutionized biology and arguably made it a science of the 21st century. One of such ...
"Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, the use of AI and machine learning (ML) have created some excitement over their potential ...
The first BioLizard Innovation Hackathon, on 14th September, was a resounding success. Four teams of our expert “Lizards” took 24 hours to develop applications that use the power of chatbots based on large language models (LLMs) to tackle challenges commonly encountered in biotech. An overarching ...
